Karyopharm Therapeutics (KPTI) PT Lowered to $8 at Piper Sandler

March 30, 2026 9:04 AM

Piper Sandler analyst Edward A. Tenthoff lowered the price target on Karyopharm Therapeutics ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found